Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.97 |
| ▸ | HPGD | P15428 | 4/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.97 |
| ▸ | RECQL | P46063 | 3/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.97 |
| ▸ | MET | P08581 | 3/20 | 0.97 |
| ▸ | KIT | P10721 | 3/20 | 0.97 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.97 |
| ▸ | SRC | P12931 | 3/20 | 0.97 |
| ▸ | KDR | P35968 | 3/20 | 0.97 |
| ▸ | G6PD | P11413 | 2/20 | 0.97 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.97 |
| ▸ | MEN1 | O00255 | 2/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.97 |
| ▸ | NSD2 | O96028 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Haematoxylin SCHEMBL29360033 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL29357236 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL1747 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL30101752 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL1784957 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL7026124 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL29363003 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL19654 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL29366910 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL30089789 | 0.99 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 907 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117016479-A | Construction method of solar dermatitis mouse model | 中国人民解放军空军特色医学中心 | 2023-11-10 | — | — | CN | claimed |
| CN-116558928-A | Red dye liquor for Masson trichromatic dyeing, reagent combination and method | 图凌(杭州)生物医药有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-111812314-B | Method for establishing complete Freund adjuvant induced frozen shoulder animal model | 嘉兴市第二医院 | 2023-03-10 | — | — | CN | claimed |
| CN-114259327-A | Method for reconstructing acetabular bone defect based on 3D printing | 常州市第一人民医院 | 2022-04-01 | — | — | CN | claimed |
| CN-113425462-A | Method for preparing metal cushion block for acetabular bone defect reconstruction through 3D printing | 常州市第一人民医院 | 2021-09-24 | — | — | CN | claimed |
| CN-111812314-A | Method for establishing complete Freund adjuvant induced frozen shoulder animal model | 嘉兴市第二医院 | 2020-10-23 | — | — | CN | claimed |
| CN-107748260-B | Experimental method for promoting tissue engineering prevascularization by umbilical cord mesenchymal stem cells | 西安组织工程与再生医学研究所 | 2020-05-15 | — | — | CN | claimed |
| US-10572996-B2 | Method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide | CONTEXTVISION AB (SE) | 2020-02-25 | — | — | US | claimed |
| EP-3475874-A1 | METHOD AND SYSTEM FOR DETECTING PATHOLOGICAL ANOMALIES IN A DIGITAL PATHOLOGY IMAGE AND METHOD FOR ANNOTATING A TISSUE SLIDE | Contextvision AB (SE) | 2019-05-01 | — | — | EP | claimed |
| CN-109187147-A | A kind of dyeing of arterial wall ingredient and identification method | 广州医科大学附属第医院 | 2019-01-11 | — | — | CN | claimed |
| US-20180112277-A1 | SIGNAL DIRECTED DISSECTION TO INFORM CANCER THERAPY STRATEGY | EXPRESSION PATHOLOGY, INC. | 2018-04-26 | — | — | US | claimed |
| US-20170372471-A1 | METHOD AND SYSTEM FOR DETECTING PATHOLOGICAL ANOMALIES IN A DIGITAL PATHOLOGY IMAGE AND METHOD FOR ANNOTATING A TISSUE SLIDE | CONTEXTVISION AB (SE) | 2017-12-28 | — | — | US | claimed |
| EP-1082611-A4 | METHOD FOR STAINING BIOLOGICAL SPECIMENS BY COMBINING UNSTABLE REAGENTS ON A MICROSCOPE SLIDE | VENTANA MED SYST INC (US) | 2003-01-15 | — | — | EP | claimed |
| EP-1082611-A1 | METHOD FOR STAINING BIOLOGICAL SPECIMENS BY COMBINING UNSTABLE REAGENTS ON A MICROSCOPE SLIDE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2001-03-14 | — | — | EP | claimed |
| WO-1999063342-A1 | METHOD FOR STAINING BIOLOGICAL SPECIMENS BY COMBINING UNSTABLE REAGENTS ON A MICROSCOPE SLIDE | VENTANA MEDICAL SYSTEMS, INC. (US) | 1999-12-09 | — | — | WO | claimed |
| US-5874315-A | Method for staining stool parasites | MERIDIAN DIAGNOSTICS, INC. (US) | 1999-02-23 | — | — | US | claimed |
| US-20240240176-A1 | PREVENTION OR TREATMENT OF MYOPATHY USING MIR-33B INHIBITOR | KYOTO UNIVERSITY (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240238346-A1 | MYOCARDIAL WOUND HEALING POST ISCHEMIC INJURY | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2024-07-18 | — | — | US | disclosed |
| US-4435407-A | ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS; IMMUNOMODULATORS | CIBA-GEIGY CORPORATION (US) | 1984-03-06 | — | — | US | disclosed |
| US-4256759-A | ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240240176-A1 | PREVENTION OR TREATMENT OF MYOPATHY USING MIR-33B INHIBITOR | MTPN, MYO3A, TNNI3 | MAPT 1201/4885KDM4E 4195/4885HPGD 4211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.